11-101583461-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004621.6(TRPC6):c.43C>T(p.Pro15Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0985 in 1,531,530 control chromosomes in the GnomAD database, including 8,033 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_004621.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRPC6 | NM_004621.6 | c.43C>T | p.Pro15Ser | missense_variant | 1/13 | ENST00000344327.8 | NP_004612.2 | |
TRPC6 | XM_047427510.1 | c.43C>T | p.Pro15Ser | missense_variant | 1/11 | XP_047283466.1 | ||
TRPC6 | XM_017018221.3 | c.43C>T | p.Pro15Ser | missense_variant | 1/11 | XP_016873710.1 | ||
TRPC6 | XM_047427509.1 | c.-89+471C>T | intron_variant | XP_047283465.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRPC6 | ENST00000344327.8 | c.43C>T | p.Pro15Ser | missense_variant | 1/13 | 1 | NM_004621.6 | ENSP00000340913.3 |
Frequencies
GnomAD3 genomes AF: 0.0719 AC: 10941AN: 152198Hom.: 525 Cov.: 33
GnomAD3 exomes AF: 0.0822 AC: 11147AN: 135616Hom.: 581 AF XY: 0.0846 AC XY: 6229AN XY: 73614
GnomAD4 exome AF: 0.101 AC: 139875AN: 1379216Hom.: 7509 Cov.: 32 AF XY: 0.101 AC XY: 68468AN XY: 678714
GnomAD4 genome AF: 0.0718 AC: 10936AN: 152314Hom.: 524 Cov.: 33 AF XY: 0.0693 AC XY: 5159AN XY: 74468
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 23, 2019 | - - |
Focal segmental glomerulosclerosis 2 Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 14, 2017 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at